Yeast-Derived Antibodies
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
96
NCT06383377
Evaluation of Performance, Safety and Benefit of the Wishbone HA as Bone Graft Substitute, a Pre-market Clinical Investigation
Phase: N/A
Role: Collaborator
Start: Apr 26, 2024
Completion: Mar 31, 2030
Loading map...